Analgesic n-(2-aminocycloaliphatic)benzamides

Claim 1

A compound of the formula ##STR64## wherein the wavy line (˜) at the 1-position of the cycloaliphatic ring denotes trans-stereoconfiguration of the 1-position substituent with respect to the substituent in position 2 of the same cycloaliphatic ring; n is 1 to 8; R is hydrogen or C 1 to C 3 -alkyl; R 1 and R 2 , taken separately, are hydrogen, C 1 to C 3 -alkyl or when R 1 is hydrogen or C 1 to C 3 -alkyl, R 2 is C 1 to C 6 -alkyl, CH 2 CF 3 , C 2 to C 5 -hydroxyalkyl, phenyl-C 2 to C 3 -alkyl, C 3 to C 6 -cycloalkyl, C 3 to C 4 -cycloalkylmethyl, and Q is 1-naphthyl, 2-naphthyl or the radical ##STR65## wherein each of X, Y and Z is hydrogen, a halogen having an atomic number of from 9 to 35, nitro, methanesulfonyl, C 1 to C 3 -alkanoyl, trifluoromethyl, C 1 to C 3 -alkyl, benzoyl or phenyl, and at least one of X, Y and Z is a substituent other than hydrogen, and when one of X, Y and Z is phenyl, the remaining X, Y or Z moieties are hydrogen, and when R is hydrogen, and n is 2 and Q is ##STR66## which is monosubstituted X and Y are hydrogen and Z cannot be methanesulfonyl, or 3-chloro; and R must be C 1 to C 3 -alkyl when n is 1, and when one of X, Y and Z is methanesulfonyl, R is C 1 to C 3 -alkyl and the pharmaceutically acceptable salts thereof.